From: Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy
C57BL/6a)
BALB/c
ICR (CD-1)
SPZ
% infected
30
60%
1,000
0%
100
100%
2,000
3,000
300
5,000
4,000
90%
10,000
80%
15,000
8,000
20,000